| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer | SVP &Chief Medical Officer
1 company
Paolini John F. is a Chief Medical Officer at KNSA. Recent filings cover 0 purchases and 30 sales.
Our model assigns Paolini John F. a middling insider score of 51/100, based on 11 past trades. Over a 12-month horizon, 22.2% of those trades were profitable, with an average 12-month return of -26.4%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Medical Officer | Sale+OE | 58,424 | $53.71 | $3,137,822.92 | -47.1% | +41.5% | - | |
| Mar 2, 2026 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Medical Officer | Sale+OE | 40,000 | $44.82 | $1,792,939.72 | -39.5% | +5.2% | - | |
| Oct 31, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Medical Officer | Sale+OE | 82,542 | $37.14 | $3,065,609.88 | -57.4% | +18.8% | - | |
| Aug 6, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Medical Officer | Sale+OE | 29,325 | $32.55 | $954,528.75 | -33.8% | +17.8% | +133.8% | |
| May 7, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Medical Officer | Sale+OE | 200 | $27.00 | $5,400.00 | -0.3% | +23.5% | +112.7% | |
| Sep 3, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Medical Officer | Sale+OE | 60,692 | $26.12 | $1,584,991.40 | -53.8% | -16.0% | +36.4% | |
| Jul 23, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Medical Officer | Sale+OE | 22,000 | $26.32 | $578,966.14 | -31.5% | -1.5% | +3.2% | |
| Mar 1, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Medical Officer | Sale+OE | 18,844 | $21.77 | $410,233.88 | -29.6% | -14.6% | -6.7% | |
| Feb 27, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Medical Officer | Sale+OE | 10,156 | $21.03 | $213,580.68 | -18.4% | -8.9% | -5.7% | |
| Dec 7, 2023 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Medical Officer | Sale+OE | 28,600 | $17.65 | $504,758.39 | -38.9% | +18.0% | +20.8% |